Completed

Effectiveness of Wallis Interspinous Dynamic Stability System for Lumbar Disc Herniation: a Prospective Randomised Controlled Study

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Lumbar discectomy

+ Lumbar discectomy combined with Wallis interspinous dynamic stability system

Procedure
Who is being recruted

Bone Diseases+4

+ Hernia

+ Musculoskeletal Diseases

From 18 to 70 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: July 2008
See protocol details

Summary

Principal SponsorGuangdong Provincial People's Hospital
Last updated: April 4, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: July 1, 2008

Actual date on which the first participant was enrolled.

The most commonly used therapy for lumbar disc herniation (LDH) are partial discectomy or discectomy with fusion if there was an additional mechanical disorder in the underlying functional spinal unit. However, the problems associated with discectomy are intervertebral disc height loss and the segmental instability, thought to be a risk for failed back surgery syndrome or recurrence lumbar disc herniation. Fusion has also been criticised for its side effects of adjacent segment degeneration(ASD), pseudarthrosis and bone-graft morbidity. To prevent such complications , a new family of dynamic implants have been established. Wallis interspinous implant (Abbott Laboratories, Bordeaux, France) , invented by J. Senegas, is one of them. It consisted of a interspinous blocker made out of polyetheretherketone (PEEK) to limit extension and two dacron tapes around the spinous processes in order to secure the implant and limit flexion. The aim of using this device is to unload the facet joints, to restore foraminal height and to provide sufficient stability especially in extension but still allow motion in the treated segment. Previous clinical trials and biomechanical studies are promising, however, the superiority of a discectomy with Wallis in comparison to a discectomy alone for primary lumbar disc herniation has yet to be determined. The purpose of this prospective controlled study was to evaluate the clinical effect of lumbar discectomy combined with Wallis interspinous device, comparing with posterior lumbar discectomy alone. Our hypothesis was that the use of the Wallis device would have better clinical and radiological outcomes than lumbar discectomy alone.

Principal SponsorGuangdong Provincial People's Hospital
Last updated: April 4, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

80 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Bone DiseasesHerniaMusculoskeletal DiseasesSpinal DiseasesPathological Conditions, Signs and SymptomsPathological Conditions, AnatomicalIntervertebral Disc Displacement

Criteria

4 inclusion criteria required to participate
18-70 years old

complaining low back pain or radioactive melosalgia

no improvement in symptoms after 6-10 weeks of non-surgical treatment

preoperative image examination showing disc herniation or spinal stenosis caused by herniation of responsible level

7 exclusion criteria prevent from participating
autoimmune diseases

congenital spinal deformity

infection

lumbar fracture

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Lumbar discectomy alone

Group II

Experimental
lumbar discectomy combined with Wallis interspinous dynamic stability system

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Guangdong Gerneral Hospital

Guangzhou, ChinaOpen Guangdong Gerneral Hospital in Google Maps
CompletedOne Study Center